Literature DB >> 8676153

Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke: relation to clinical outcome.

A E Baird1, M C Austin, W J McKay, G A Donnan.   

Abstract

BACKGROUND: One major therapeutic strategy to minimise the extent of infarction after ischaemic stroke is to improve early reperfusion using thrombolytic agents. However, reperfusion may be hazardous and the period during which reperfusion may have a beneficial effect on tissue and clinical outcome is not known.
METHODS: Fifty three patients were studied with serial cerebral perfusion (99mTcHMPAO SPECT) during the first 48 hours of ischaemic stroke to determine if changes in tissue perfusion during this time were prognostically significant. Single and multiple linear regression non-parametric analyses were used to include other factors during the same period which may influence outcome.
RESULTS: In univariate analysis age, neurological score at admission, SPECT perfusion defect size in the first 24 hours, and percentage change in cerebral tissue perfusion at 24-48 hours (all P < 0.01) correlated significantly with the Barthel score at three months. In multiple linear regression analysis only age (P < 0.01) and percentage change in cerebral tissue perfusion at 24-48 hours (P < 0.01) provided independent prognostic information at three months.
CONCLUSIONS: Changes in cerebral tissue perfusion during the first 48 hours of ischaemic stroke are significant outcome predictors and therapeutic effort aimed at increasing perfusion during this period seem to be justified.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8676153      PMCID: PMC486451          DOI: 10.1136/jnnp.61.1.26

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  30 in total

1.  Pathophysiology of acute ischaemic stroke.

Authors:  W Pulsinelli
Journal:  Lancet       Date:  1992-02-29       Impact factor: 79.321

2.  Progressive derangement of periinfarct viable tissue in ischemic stroke.

Authors:  W D Heiss; M Huber; G R Fink; K Herholz; U Pietrzyk; R Wagner; K Wienhard
Journal:  J Cereb Blood Flow Metab       Date:  1992-03       Impact factor: 6.200

3.  Predicting the outcome of stroke: acute stage after cerebral infarction.

Authors:  J M Oxbury; R C Greenhall; K M Grainger
Journal:  Br Med J       Date:  1975-07-19

4.  Prognosis of acute stroke.

Authors:  B R Chambers; J W Norris; B L Shurvell; V C Hachinski
Journal:  Neurology       Date:  1987-02       Impact factor: 9.910

5.  Thresholds in cerebral ischemia - the ischemic penumbra.

Authors:  J Astrup; B K Siesjö; L Symon
Journal:  Stroke       Date:  1981 Nov-Dec       Impact factor: 7.914

6.  Value and limitations of echocardiography in endocarditis. Editorial comments to the paper by Burger et al.

Authors:  E A Amsterdam
Journal:  Cardiology       Date:  1984       Impact factor: 1.869

7.  Patterns of stroke. An analysis of the first 700 consecutive admissions to the Austin Hospital Stroke Unit.

Authors:  B R Chambers; G A Donnan; P F Bladin
Journal:  Aust N Z J Med       Date:  1983-02

8.  Predictive value of perfusion defect size using N-isopropyl-(I-123)-p-iodoamphetamine emission tomography in acute stroke.

Authors:  R G Lee; T C Hill; B L Holman; H D Royal; D H O'Leary; M E Clouse
Journal:  J Neurosurg       Date:  1984-09       Impact factor: 5.115

9.  Early and delayed SPECT using N-isopropyl p-iodoamphetamine iodine 123 in cerebral ischemia. A prognostic index for clinical recovery.

Authors:  G Defer; J L Moretti; P Cesaro; A Sergent; C Raynaud; J D Degos
Journal:  Arch Neurol       Date:  1987-07

10.  Variability and reversibility of focal cerebral ischemia in unanesthetized monkeys.

Authors:  R M Crowell; F W Marcoux; U DeGirolami
Journal:  Neurology       Date:  1981-10       Impact factor: 9.910

View more
  3 in total

1.  Monitoring Pressure Augmentation in Patients With Ischemic Penumbra Using Continuous Electroencephalogram: Three Cases and a Review of the Literature.

Authors:  Christopher R Newey; Vikas Gupta; Agnieszka A Ardelt
Journal:  Neurohospitalist       Date:  2017-05-11

Review 2.  Vectorized nanodelivery systems for ischemic stroke: a concept and a need.

Authors:  Andrés Da Silva-Candal; Bárbara Argibay; Ramón Iglesias-Rey; Zulema Vargas; Alba Vieites-Prado; Esteban López-Arias; Emilio Rodríguez-Castro; Iria López-Dequidt; Manuel Rodríguez-Yáñez; Yolanda Piñeiro; Tomás Sobrino; Francisco Campos; José Rivas; José Castillo
Journal:  J Nanobiotechnology       Date:  2017-04-11       Impact factor: 10.435

3.  Vascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework.

Authors:  Hanne Stotesbury; Jamie M Kawadler; Patrick W Hales; Dawn E Saunders; Christopher A Clark; Fenella J Kirkham
Journal:  Front Neurol       Date:  2019-08-13       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.